Ímpar Serviços Hospitalares (DASA) acquired H.I.G. Capital-backed Clínica AMO, an independent cancer center oncology clinic in Brazil, for BRL750m (~USD148.5m). The transaction remains subject to customary closing conditions. H.I.G. Capital previously invested in 2018 in AMO.
(Press Release) H.I.G. Capital (“H.I.G.”), a leading global alternative investment firm with $44 billion of assets under management, announced today the signing of a definitive agreement to sell Clínica AMO (“AMO” or the “Company”) to Ímpar Serviços Hospitalares (“DASA”). H.I.G., through an affiliate, holds a significant minority equity stake in AMO, which is controlled by Dr. Carlos Sampaio. The transaction remains subject to customary closing conditions.
In announcing the transaction, Marcelo Hudik, Managing Director of H.I.G. Brazil and Latin America, commented: “It has been a privilege to support the Company in executing its organic and inorganic strategy, including the completion of several acquisitions in the northeast and the development of its diagnostic center, creating the first comprehensive cancer center in the region. I would like to thank and congratulate Dr. Carlos Sampaio and the management team.”
On behalf of AMO’s controlling shareholders, Dr. Carlos Sampaio noted: “In the last three years of our partnership with H.I.G., AMO has grown and strengthened itself, consolidating its position as the leading oncology center in the northeast after successfully entering in the states of Sergipe and Rio Grande do Norte. We are thankful to H.I.G. for having believed in our business and expansion plan; sharing the vision of offering the most advanced and comprehensive oncology treatments to patients; for its partnership; and for being part of this successful investment. We are confident that DASA will continue its tradition of providing outstanding cancer treatment and focus on patient care. We will be following the Company’s progress closely in the next phase of its development.”
About H.I.G. Capital
H.I.G. is a leading global private equity and alternative assets investment firm with $44 billion of equity capital under management.* Based in Miami, and with offices in New York, Boston, Chicago, Dallas, Los Angeles, San Francisco, and Atlanta in the U.S., as well as international affiliate offices in London, Hamburg, Madrid, Milan, Paris, Bogotá, Rio de Janeiro and São Paulo, H.I.G. specializes in providing both debt and equity capital to small and mid-sized companies, utilizing a flexible and operationally focused/ value-added approach. Since its founding in 1993, H.I.G. has invested in and managed more than 300 companies worldwide. The firm’s current portfolio includes more than 100 companies with combined sales in excess of $30 billion. For more information, please refer to the H.I.G. website at www.higcapital.com.
About AMO
Founded in 1993 and headquartered in Salvador, AMO is the largest group of oncology clinics in the State of Bahia, in Brazil’s northeast region. The Company operates fifteen units in the states of Bahia, Sergipe and Rio Grande do Norte, offering comprehensive treatments for more than 10 cancer specialties with its team of over 250 doctors and nurses. Additionally, the Company is among a select group of 6 organizations outside the U.S. with a distinguished quality certification from the American Society of Clinical Oncology (ASCO). In 2018, the Company received a capital injection from H.I.G. Capital to support its organic and inorganic expansion agenda. For more information visit https://www.clinicaamo.com.br/.
* Based on total capital commitments managed by H.I.G. Capital and affiliates.
Contacts
H.I.G. Capital
Marcelo Hudik
Managing Director
mhudik@higcapital.com
T +55 21 2529-3550
F +55 21 2529-3551
www.higcapital.br.com
